The evolution of commercial drug delivery technologies
AM Vargason, AC Anselmo, S Mitragotri - Nature biomedical …, 2021 - nature.com
Drug delivery technologies have enabled the development of many pharmaceutical
products that improve patient health by enhancing the delivery of a therapeutic to its target …
products that improve patient health by enhancing the delivery of a therapeutic to its target …
Cancer-associated adipocytes: key players in breast cancer progression
Q Wu, B Li, Z Li, J Li, S Sun, S Sun - Journal of hematology & oncology, 2019 - Springer
Adipocytes are one of the primary stromal cells in many tissues, and they are considered to
play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) …
play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) …
The landscape of targeted therapies in TNBC
E Vagia, D Mahalingam, M Cristofanilli - Cancers, 2020 - mdpi.com
Triple negative breast cancer (TNBC) constitutes the most aggressive molecular subtype
among breast tumors. Despite progress on the underlying tumor biology, clinical outcomes …
among breast tumors. Despite progress on the underlying tumor biology, clinical outcomes …
Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors
TK Rimkus, RL Carpenter, S Qasem, M Chan, HW Lo - Cancers, 2016 - mdpi.com
The sonic hedgehog (Shh) signaling pathway is a major regulator of cell differentiation, cell
proliferation, and tissue polarity. Aberrant activation of the Shh pathway has been shown in …
proliferation, and tissue polarity. Aberrant activation of the Shh pathway has been shown in …
New angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis
I Larionova, E Kazakova, T Gerashchenko… - Cancers, 2021 - mdpi.com
Simple Summary Since the targeting of a single pro-angiogenic factor fails to improve
oncological disease outcome, significant efforts have been made to identify new pro …
oncological disease outcome, significant efforts have been made to identify new pro …
Secondary arterial hypertension: when, who, and how to screen?
SF Rimoldi, U Scherrer, FH Messerli - European heart journal, 2014 - academic.oup.com
Secondary hypertension refers to arterial hypertension due to an identifiable cause and
affects∼ 5–10% of the general hypertensive population. Because secondary forms are rare …
affects∼ 5–10% of the general hypertensive population. Because secondary forms are rare …
Recent advances in nanostrategies capable of overcoming biological barriers for tumor management
Engineered nanomaterials have been extensively employed as therapeutics for tumor
management. Meanwhile, the complex tumor niche along with multiple barriers at the …
management. Meanwhile, the complex tumor niche along with multiple barriers at the …
[HTML][HTML] Targeting the tumor vasculature to enhance T cell activity
Highlights•Tumor vessels form a physical barrier that hampers intratumoral T cell
trafficking.•Tumor endothelial cells can directly kill T cells or suppress their …
trafficking.•Tumor endothelial cells can directly kill T cells or suppress their …
Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: potencial clinical application
C Merino-González, FA Zuñiga, C Escudero… - Frontiers in …, 2016 - frontiersin.org
Mesenchymal stem cells (MSCs) are adult multipotent stem cells that are able to differentiate
into multiple specialized cell types including osteocytes, adipocytes, and chondrocytes …
into multiple specialized cell types including osteocytes, adipocytes, and chondrocytes …
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Nanoparticles, especially liposomes, have gained prominence in the field of drug delivery
for the treatment of human diseases, particularly cancer; they provide several advantages …
for the treatment of human diseases, particularly cancer; they provide several advantages …